Arbet-Engels Christophe
Insider CIK 1802615 · ALT Chief Medical Officer · XFOR Chief Medical Officer · MLND Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALT Altimmune, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-05 | 37,500 | — | $0 | 112,500 | SEC↗ |
| ALT Altimmune, Inc. | F Tax w/h | 2026-10-01 | 2026-10-05 | 12,679 | $2.76 | $35.0K | 24,821 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2026-10-01 | 2026-10-05 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-02-12 | 2025-02-14 | 850,000 | — | $0 | 864,207 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2025-01-24 | 2025-01-27 | 11,624 | $0.45 | $5.2K | 14,207 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-01-23 | 2025-01-27 | 25,831 | — | $0 | 25,831 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2024-02-13 | 2024-02-16 | 475,831 | — | $0 | 475,831 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2024-02-13 | 2024-02-28 | 180,816 | — | $0 | 180,816 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2023-08-31 | 2023-09-05 | 1,250,000 | $1.28 | $1.60M | 1,250,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2020-05-25 | 2020-05-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2020-02-10 | 2020-02-11 | 140,000 | — | $0 | 140,000 | SEC↗ |